- Home
- SGMO vs SCLXW Comparison
SGMO vs SCLXW Comparison
Compare SGMO & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- SCLXW
- Stock Information
- Founded
- SGMO 1995
- SCLXW N/A
- Country
- SGMO United States
- SCLXW United States
- Employees
- SGMO N/A
- SCLXW 115
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- SCLXW Biotechnology: Pharmaceutical Preparations
- Sector
- SGMO Health Care
- SCLXW Health Care
- Exchange
- SGMO Nasdaq
- SCLXW Nasdaq
- Market Cap
- SGMO N/A
- SCLXW N/A
- IPO Year
- SGMO 2000
- SCLXW N/A
- Fundamental
- Price
- SGMO $0.70
- SCLXW $0.08
- Analyst Decision
- SGMO Buy
- SCLXW
- Analyst Count
- SGMO 6
- SCLXW 0
- Target Price
- SGMO $5.17
- SCLXW N/A
- AVG Volume (30 Days)
- SGMO 4.3M
- SCLXW 4.0K
- Earning Date
- SGMO 05-20-2025
- SCLXW 03-07-2025
- Dividend Yield
- SGMO N/A
- SCLXW N/A
- EPS Growth
- SGMO N/A
- SCLXW N/A
- EPS
- SGMO N/A
- SCLXW N/A
- Revenue
- SGMO $57,800,000.00
- SCLXW $55,152,000.00
- Revenue This Year
- SGMO N/A
- SCLXW N/A
- Revenue Next Year
- SGMO $15.47
- SCLXW N/A
- P/E Ratio
- SGMO N/A
- SCLXW N/A
- Revenue Growth
- SGMO N/A
- SCLXW 22.02
- 52 Week Low
- SGMO $0.30
- SCLXW $0.18
- 52 Week High
- SGMO $3.18
- SCLXW $0.18
- Technical
- Relative Strength Index (RSI)
- SGMO 46.14
- SCLXW N/A
- Support Level
- SGMO $0.52
- SCLXW N/A
- Resistance Level
- SGMO $0.75
- SCLXW N/A
- Average True Range (ATR)
- SGMO 0.08
- SCLXW 0.00
- MACD
- SGMO 0.00
- SCLXW 0.00
- Stochastic Oscillator
- SGMO 56.31
- SCLXW 0.00
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.